continuous subcutaneous insulin infusion


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia.
Related to continuous subcutaneous insulin infusion: insulin pump

continuous subcutaneous insulin infusion

delivery of insulin to subcutaneous tissue by a pump using both continuous and bolus infusions.

continuous subcutaneous insulin infusion

Abbreviation: CSII
Administration of insulin under the skin continuously with an infusion pump connected to a needle inserted beneath the epidermis.
See: insulin pump
See also: infusion
References in periodicals archive ?
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.
Quality of life and metabolic control in patients with diabetes mellitus type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections.
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.
Guidance on the use of continuous subcutaneous insulin infusion for diabetes.
Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
Troup, TX, August 18, 2012 --(PR.com)-- Pedagogy, Inc., a national provider of online continuing education and training courses for nurses and other health care professionals, is very pleased to announce an important new course on Continuous Subcutaneous Insulin Infusion authored by Judy Gilman NP-R, RN, CDE.
A closed-loop system linking continuous glucose measurements to insulin delivery reduced the risk of nocturnal hypoglycemia compared with standard continuous subcutaneous insulin infusion in a three-part randomized crossover study involving 17 children and adolescents with type 1 diabetes.
In vitro stability of insulin lispro in continuous subcutaneous insulin infusion. Diabetes Technol Ther.
Current perspectives on the use of continuous subcutaneous insulin infusion in the acute care setting and overview of therapy.
The aim of this randomised controlled study was to compare continuous subcutaneous insulin infusion using an insulin pump with the traditional continuous intravenous infusion method for tight glycaemic control.
The popularity of continuous subcutaneous insulin infusion (CSII) for children and adolescents with type 1 diabetes has increased, despite limited safety and effectiveness data, in part because many children and teens prefer the customized insulin delivery of a pump rather than multiple daily insulin injections.
Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience.

Full browser ?